Ixazomib, Rituximab And Dexamethasone (Ird) In Patients With Relapsed Or Progressive Waldenstrom'S Macroblobulinemia: Results Of The Prospective Phase I/Ii Hovon 124/Ecwm-R2 Trial

BLOOD(2019)

引用 8|浏览54
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要